Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11397188
Method of detecting an APP Alzheimer's disease marker peptide in patients with Alzheimer's disease
granted -
US 11397184
Selection of patients for combination therapy
granted -
US 11396540
Methods for making recombinant proteins
granted -
US 11395855
Exon skipping oligomer conjugates for muscular dystrophy
granted -
US 11395850
RSV vaccines and methods of production and use thereof
granted -
US 11395838
Methods for enhancing immune checkpoint blockade therapy by modulating the microbiome
granted -
US 11395817
Methods and compositions for treatment of epileptic disorders
granted -
US 11396571
Polymers including galactose based blocks and uses thereof
granted -
US 11396506
Amino acid compounds with unbranched linkers and methods of use
granted -
US 11395854
Trialkyl cationic lipids and methods of use thereof
granted -
US 11395848
Methods and compositions for treating diabetes
granted -
US 11396495
Amine compound for inhibiting SSAO/VAP-1 and use thereof
granted -
US 11395822
Methods for treating Huntington's disease
granted -
US 11396654
Neutral nanotransporters
granted -
US 11396647
Human methylthioadenosine/adenosine depleting enzyme variants for cancer therapy
granted -
US 11389517
Peptide conjugated particles
granted -
US 11390861
CRISPR/cas-related methods and compositions for treating herpes simplex virus
granted -
US 11390687
Bispecific antibodies against plasma kallikrein and Factor XII
granted -
US 11390682
Methods of intravenouisly delivering anti-transferrin antibody/oligonucleotide complexes to subjects having muscular dystrophy
granted -
US 11390634
Fused heterocyclic compound
granted -
US 11390646
Structure-based peptide inhibitors of α-synuclein aggregation
granted -
US 11390605
Substituted pyrimidine compounds as multifunctional radical quenchers and their uses
granted -
US 11390588
2-substituted amino-naphth (1,2-d) imidazol-5-one compounds of pharmaceutically acceptable salts thereof
granted -
US 11390606
Pyridazinone compounds and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.